|
FY2025
12 months to Aug 31, 2025
|
FY2012
12 months to Aug 31, 2012
|
FY2011
8 months to Aug 31, 2011
|
|
|---|---|---|---|
| Net income | |||
| Net loss | |||
| Depreciation and amortization expense | |||
| Amortization of debt discount | |||
| Provision for credit losses | |||
| Gain on debt exchange for series B convertible preferred stock | |||
| Loss recognized upon dissolution of DrivenIQ | |||
| Stock-based compensation expense - primarily related party (see Notes 12 and 13) | |||
| (Increase) decrease in accounts receivable | |||
| Decrease in prepaid expenses and other current assets | |||
| Increase in accounts payable and accrued liabilities | |||
| Increase in accrued interest | |||
| Increase (decrease) in deferred revenue | |||
| Net cash used in operating activities | |||
| Capitalized software development costs | |||
| Payments received on notes receivable | |||
| Issuance of notes receivable | |||
| Net cash used in investing activities | |||
| Payment on other notes payable | |||
| Issuance of convertible notes payable | |||
| Payments on insurance financing arrangement | |||
| Net cash provided by financing activities | |||
| Net decrease in cash | |||
| Cash at beginning of the year | |||
| Cash at end of the year | |||
| Non-cash investing & financing activities: | |||
| Exchange of convertible notes payable and accrued interest for Series B convertible preferred stock | |||
| Exchange of Series B convertible preferred stock for Series C convertible stock | |||
| Exchange of common stock for Series B convertible preferred stock | |||
| Insurance financing agreement | |||
Loading...